Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0Q2CR
|
||||
Former ID |
DNC014004
|
||||
Drug Name |
1-(1,3,4-Oxadiazol-2-yl)-7-phenylheptan-1-one
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Discovery agent | Investigative | [529594] | ||
Structure |
![]() |
Download2D MOL |
|||
Formula |
C15H18N2O2
|
||||
Canonical SMILES |
C1=CC=C(C=C1)CCCCCCC(=O)C2=NN=CO2
|
||||
InChI |
1S/C15H18N2O2/c18-14(15-17-16-12-19-15)11-7-2-1-4-8-13-9-5-3-6-10-13/h3,5-6,9-10,12H,1-2,4,7-8,11H2
|
||||
InChIKey |
SRGOKBDAYNCSOV-UHFFFAOYSA-N
|
||||
PubChem Compound ID | |||||
Target and Pathway | |||||
Target(s) | Fatty-acid amide hydrolase | Target Info | Inhibitor | [529594] | |
BioCyc Pathway | Anandamide degradation | ||||
KEGG Pathway | Retrograde endocannabinoid signaling | ||||
PANTHER Pathway | Anandamide degradation | ||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.